What is Unilever reportedly considering regarding Thorne, and how does this fit into its broader strategic direction?

Unilever is exploring a bid for Thorne, a U.S. dietary supplements maker valued at up to $4 billion, as part of its accelerated pivot toward beauty and wellbeing brands.

Who currently owns Thorne, and what other strategic interest has the company attracted?

Thorne was acquired in 2023 by L Catterton — a private equity firm backed by LVMH — for $680 million, and has also attracted a bid from consumer healthcare group Haleon, according to two sources familiar with the matter.

Unilever explores bid for supplements maker Thorne, FT reports

Jun 26, 2026

Unilever is exploring a bid for U.S. supplements maker Thorne, valued at up to $4 billion, to accelerate its pivot toward wellbeing brands. Thorne produces dietary supplements such as magnesium and omega-3 and faces competition from other bidders like Haleon.

reuters

2026-02-26

Univar, Ingredion sign pharmaceutical distribution deal for US, Canada

2026-03-11

Univar, SI Group Expand EMEA Distribution Partnership for Performance Additives

2026-04-14

Unilever Bets Big on Gummies as Next Frontier in Wellness

2026-04-27

Hungary's MOL Says Talks on NIS Acquisition Ongoing

2026-05-14

Britain's Tate & Lyle in discussions with US rival Ingredion for $3.7 billion takeover bid